New Microbiologica

Scope & Guideline

Connecting science and health through groundbreaking microbiological studies.

Introduction

Welcome to your portal for understanding New Microbiologica, featuring guidelines for its aims and scope. Our guidelines cover trending and emerging topics, identifying the forefront of research. Additionally, we track declining topics, offering insights into areas experiencing reduced scholarly attention. Key highlights include highly cited topics and recently published papers, curated within these guidelines to assist you in navigating influential academic dialogues.
LanguageEnglish
ISSN1121-7138
PublisherEDIZIONI INT SRL
Support Open AccessNo
CountryItaly
TypeJournal
Convergefrom 1993 to 2024
AbbreviationNEW MICROBIOL / New Microbiol.
Frequency4 issues/year
Time To First Decision-
Time To Acceptance-
Acceptance Rate-
Home Page-
AddressVIA SPADOLINI 7, MILANO 20141, ITALY

Aims and Scopes

The journal 'New Microbiologica' is dedicated to the dissemination of research on diverse aspects of microbiology, particularly focusing on infectious diseases, antimicrobial resistance, and the interplay between pathogens and hosts. Its comprehensive approach includes clinical studies, laboratory research, and public health implications, making it a vital resource for researchers and healthcare professionals alike.
  1. Infectious Diseases and Epidemiology:
    The journal emphasizes the study of infectious diseases, including their epidemiology, clinical features, and outcomes. Research often focuses on the prevalence and impact of various pathogens in different populations.
  2. Antimicrobial Resistance:
    A significant theme in the journal is the exploration of antimicrobial resistance patterns among various pathogens, helping to inform treatment strategies and public health initiatives.
  3. Clinical Microbiology and Diagnostics:
    The journal publishes studies on the diagnostic methods for identifying pathogens, including innovations in laboratory techniques and their application in clinical settings.
  4. Host-Pathogen Interactions:
    Research on the interactions between pathogens and their hosts is a core area, providing insights into disease mechanisms and potential therapeutic targets.
  5. Innovative Therapeutic Approaches:
    The journal highlights novel treatment strategies, including combination therapies and the use of new antimicrobial agents, reflecting ongoing efforts to combat resistant infections.
  6. Public Health and Policy Implications:
    Studies that connect microbiological research with public health policy are prevalent, addressing issues such as vaccination strategies, infection control measures, and health education.
The journal 'New Microbiologica' has seen the rise of several emerging themes in recent years, reflecting current challenges and advancements in microbiological research. These trends indicate the journal's responsiveness to global health issues and scientific innovations.
  1. COVID-19 and Associated Infections:
    Research related to COVID-19, including its clinical impact, co-infections, and long-term effects, has surged, highlighting the pandemic's influence on current microbiological research priorities.
  2. Molecular Epidemiology and Genomic Studies:
    There is a growing trend towards genomic epidemiology, with studies focusing on the genetic characterization of pathogens, particularly in relation to antibiotic resistance and outbreak investigations.
  3. Innovations in Antimicrobial Susceptibility Testing:
    Recent publications emphasize advancements in antimicrobial susceptibility testing methodologies, reflecting a need for rapid and accurate diagnostics in clinical microbiology.
  4. Viral Infections and Co-Infections:
    The investigation of viral pathogens, particularly their interactions with other pathogens and their role in disease severity, has gained prominence, especially in the context of respiratory viruses.
  5. Public Health Strategies for Infection Control:
    Emerging themes include public health strategies aimed at controlling infectious diseases, with an emphasis on vaccination, surveillance, and health policy to mitigate outbreaks.

Declining or Waning

While the journal covers a broad range of topics in microbiology, certain themes have shown a decline in publication frequency, reflecting shifts in research focus and emerging priorities within the field.
  1. Traditional Antibiotic Studies:
    There appears to be a waning interest in studies solely focused on traditional antibiotics without consideration of resistance patterns or combination therapies, as the field moves towards a more integrated approach to antimicrobial treatment.
  2. Basic Laboratory Techniques:
    Papers focusing exclusively on basic microbiological laboratory techniques are becoming less common as the field emphasizes more complex methodologies and technologies, such as molecular diagnostics and next-generation sequencing.
  3. Non-Infectious Microbial Studies:
    Research that does not directly relate to infectious diseases, such as studies on microbiomes in non-clinical settings, is less frequently published, possibly in favor of more clinically relevant microbiological research.

Similar Journals

JOURNAL OF BIOMEDICAL SCIENCE

Innovating biomedicine: Where research meets accessibility.
Publisher: BMCISSN: 1021-7770Frequency: 1 issue/year

JOURNAL OF BIOMEDICAL SCIENCE, published by BMC, is a premier Open Access journal dedicated to the rapid dissemination of research in the fields of biomedical science, encompassing crucial areas such as biochemistry, cell biology, clinical biochemistry, and more. Since its inception in 1993, the journal has established itself as a leading publication, currently boasting a remarkable impact factor and quality as evidenced by its Q1 quartile rankings across multiple categories in 2023. With an impressive track record, including a Scopus ranking in the top percentiles across several disciplines, it serves as a vital resource for researchers, professionals, and students who are keen on advancing their knowledge in biomedicine. The journal operates under a fully Open Access model, ensuring that all published articles are freely available to the global research community, thus contributing to the broader dissemination and accessibility of scientific knowledge. Based in the United Kingdom, JOURNAL OF BIOMEDICAL SCIENCE is committed to fostering innovation and collaboration in research, appealing to those aiming to make impactful contributions to the biomedical sphere.

Journal of Laboratory Physicians

Fostering collaboration for a brighter future in laboratory medicine.
Publisher: THIEME MEDICAL PUBL INCISSN: 0974-2727Frequency: 4 issues/year

The Journal of Laboratory Physicians is a prestigious, peer-reviewed publication dedicated to advancing the field of laboratory medicine. Published by THIEME MEDICAL PUBL INC, this journal has established itself as a vital source of research and clinical insights since its inception, transitioning to Open Access in 2009 to broaden its reach and accessibility. With an ISSN of 0974-2727 and an E-ISSN of 0974-7826, it aims to provide a platform for professionals, researchers, and students engaged in laboratory-based studies to share critical findings and foster collaboration across disciplines. The journal's scope encompasses a wide range of topics relevant to laboratory physicians, ensuring that it remains an essential resource for those seeking to stay on the cutting edge of laboratory practices and innovations. By disseminating timely research and reviews, the Journal of Laboratory Physicians plays a crucial role in enhancing the quality of healthcare through improved laboratory services.

INTERNATIONAL JOURNAL OF MEDICAL MICROBIOLOGY

Fostering Global Collaboration in Microbial Research
Publisher: ELSEVIER GMBHISSN: 1438-4221Frequency: 8 issues/year

Welcome to the International Journal of Medical Microbiology, a leading publication in the field of microbiological research and infectious diseases, offered by Elsevier GmbH. Established in 2000, this esteemed journal provides a scholarly platform for the presentation of high-quality research, reviews, and innovations that bridge medical microbiology and clinical applications. With an impressive impact factor positioning it within the Q1 category across multiple disciplines, including Infectious Diseases, Microbiology, and Medicine, the journal is recognized for its rigorous peer-review process and significant contributions to advancing our understanding of microbial pathogenesis, diagnostics, and therapeutics. The International Journal of Medical Microbiology is committed to open access, promoting the dissemination of knowledge and accessibility for researchers, professionals, and students worldwide. Based in Munich, Germany, the journal continues to play a vital role in the global scientific community, fostering collaborations and inspiring future innovations in the fight against infectious diseases.

Current Clinical Microbiology Reports

Transforming Knowledge into Action Against Infectious Diseases
Publisher: SPRINGERISSN: 2196-5471Frequency: 4 issues/year

Current Clinical Microbiology Reports, published by Springer, is a leading international journal dedicated to advancing the field of clinical microbiology. With a focus on the diagnosis, treatment, and prevention of infectious diseases, this journal serves as a vital resource for researchers, medical professionals, and students engaged in microbiological studies. As a testament to its quality and influence, it holds an impressive impact factor and ranks in the Q1 category in both Infectious Diseases and Microbiology (medical), reflecting its prominent standing in the scholarly community. Additionally, it features a commendable Scopus ranking, placing it in the 77th percentile for Medicine - Infectious Diseases and the 69th percentile for Medicine - Microbiology (medical). With contributions spanning over a decade, from 2014 to 2024, the journal continues to publish high-quality research articles that shape the future of clinical practices and public health policies. While access options are variable, the journal's commitment to open dialogue and dissemination of knowledge makes it a pivotal platform for those passionate about tackling microbial challenges in healthcare.

Mediterranean Journal of Infection Microbes and Antimicrobials

Unlocking insights into the realm of infectious microbes.
Publisher: GALENOS PUBL HOUSEISSN: 2147-673XFrequency: 1 issue/year

Mediterranean Journal of Infection Microbes and Antimicrobials is a distinguished open-access journal published by GALENOS PUBL HOUSE, dedicated to advancing the understanding of infectious diseases and microbiology. Since its inception in 2011, this journal has been a vital resource for researchers, professionals, and students interested in the intricate world of microbes and their impacts on human health. With its ISSN 2147-673X, the journal has progressively gained visibility, although it currently holds a Q4 ranking in multiple categories including Immunology and Microbiology, and Infectious Diseases for the year 2023. The journal operates from its headquarters in Istanbul, Turkey, and features a rich array of articles that contribute to the field’s body of knowledge. As a platform enhancing the accessibility of research, it invites submissions from global contributors to foster collaboration and innovation in tackling microbial challenges.

CLINICAL MICROBIOLOGY AND INFECTION

Elevating Standards in Microbial Research
Publisher: ELSEVIER SCI LTDISSN: 1198-743XFrequency: 12 issues/year

CLINICAL MICROBIOLOGY AND INFECTION is a leading journal published by Elsevier Science Ltd, dedicated to advancing the field of infectious diseases and clinical microbiology. With its ISSN 1198-743X and E-ISSN 1469-0691, this esteemed journal has maintained its influential presence since 1995, showcasing high-impact research that addresses critical issues in the diagnosis, treatment, and prevention of infections. Ranked in the Q1 quartile for Infectious Diseases, Medicine (miscellaneous), and Microbiology (medical) categories, and boasting impressive Scopus rankings of #12 and #7 respectively, it sits at the forefront of scientific inquiry in these disciplines. Although it is not an Open Access journal, it provides comprehensive access options for institutions and individuals, ensuring the dissemination of vital research findings. As the field of clinical microbiology continues to evolve, CLINICAL MICROBIOLOGY AND INFECTION remains an essential resource for researchers, clinicians, and students aiming to stay informed on the latest developments and breakthroughs in understanding infectious diseases.

MEDICAL MICROBIOLOGY AND IMMUNOLOGY

Driving innovation in the study of microbes and their immune interactions.
Publisher: SPRINGERISSN: 0300-8584Frequency: 6 issues/year

Medical Microbiology and Immunology is a renowned journal published by Springer, serving as a pivotal resource in the fields of microbiology and immunology. Established in 1971 and continuing its legacy through 2024, this journal features cutting-edge research and reviews that address critical advancements and challenges within these dynamic fields. With an impressive impact factor and a robust ranking, including Q1 categories in both Microbiology (medical) and Immunology, it stands at the forefront of scholarly communication, ranking 21st out of 140 in the realm of Medical Microbiology. Researchers and professionals are encouraged to explore a variety of studies that delve into the interactions between microorganisms and the immune system, making it an essential resource for anyone fascinated by these interconnected realms of health sciences. Although not open access, the journal is widely accessible through institutional libraries, ensuring that significant findings reach a global audience. The University of New York Plaza serves as its operational hub in the USA, reinforcing its international influence and dedication to advancing knowledge in microbiology and immunology.

MICROBES AND INFECTION

Transforming Knowledge into Clinical Practice
Publisher: ELSEVIERISSN: 1286-4579Frequency: 12 issues/year

MICROBES AND INFECTION is a premier academic journal published by Elsevier, dedicated to the dynamic fields of immunology, infectious diseases, and microbiology. With a notable impact factor reflective of its high-quality research contributions, the journal is categorized in the Q2 quartile across these fields as of 2023. Based in France and operating since 1999, MICROBES AND INFECTION offers a platform for researchers, professionals, and students to disseminate and access cutting-edge findings that drive innovation and knowledge in microbial and infectious disease research. The journal is ranked impressively within the Scopus database, securing ranks such as #16 in Microbiology and #33 in Infectious Diseases, underscoring its high relevance in the scientific community. Subscribers to the journal can expect an array of articles, reviews, and original research, all designed to advance understanding and improve clinical practices in the fight against infectious agents. With its ongoing commitment to open access options, MICROBES AND INFECTION continues to foster global collaboration and information sharing in the pursuit of addressing pressing microbiological challenges.

Infectious Diseases and Clinical Microbiology

Bridging research and clinical practice in infectious health.
Publisher: DOC DESIGN INFORMATICS CO LTDISSN: 2667-646XFrequency: 4 issues/year

Infectious Diseases and Clinical Microbiology is a pivotal journal dedicated to advancing our understanding of infectious diseases through rigorous scientific research and clinical practices. Published by DOC DESIGN INFORMATICS CO LTD, this journal serves as a vital platform for researchers, healthcare professionals, and students keen on enhancing their knowledge of microbiological sciences and the clinical implications of infectious agents. With an ISSN of 2667-646X, it aims to disseminate significant findings in the field, enriching the scholarly dialogue surrounding infectious diseases. While currently operating under a traditional access model, the journal encourages global collaboration and knowledge sharing, striving to make a meaningful impact in tackling the challenges posed by infectious diseases. Its content aims to bridge the gap between laboratory research and clinical application, making it an essential resource in the contemporary landscape of global health.

INFECTION

Leading the Charge in Microbial Research
Publisher: SPRINGER HEIDELBERGISSN: 0300-8126Frequency: 6 issues/year

INFECTION is a prestigious journal, published by Springer Heidelberg, that serves as a leading platform for the dissemination of critical research in the fields of Infectious Diseases, Microbiology, and Medicine. With an impressive Q1 ranking in multiple categories such as Infectious Diseases, Medicine (miscellaneous), and Medical Microbiology, the journal is recognized for its high-quality content and impactful contributions to the scientific community, as evidenced by its Scopus rankings placing it in the top 10th percentiles. Since its inception in 1973, and projected to continue until 2024, INFECTION has established itself as a vital resource for researchers, healthcare professionals, and students keen to explore the latest findings and advancements in infectious diseases. The journal provides a rigorous peer-review process, ensuring that only high-quality studies are published, making it an essential read for those seeking to deepen their understanding and stay abreast of the rapidly evolving landscape in infection research.